Enact Holdings (ACT) Cash & Equivalents (2020 - 2026)

Enact Holdings' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $549.0 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 13.57% year-over-year to $549.0 million in Q1 2026; TTM through Mar 2026 was $549.0 million, a 13.57% decrease from a year earlier, with the FY2025 full-year figure at $582.5 million, down 2.83% from the prior year.
• Cash & Equivalents fell to $549.0 million in Q1 2026 per ACT's latest filing, from $582.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $699.0 million in Q2 2024 and bottomed at $440.2 million in Q1 2022.
• The 5-year median for Cash & Equivalents is $613.0 million (2025), against an average of $599.4 million.
• Across the five-year window, Cash & Equivalents soared 41.23% in 2023 and declined 19.27% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $513.8 million in 2022, then advanced by 19.84% to $615.7 million in 2023, then decreased by 2.64% to $599.4 million in 2024, then declined by 2.83% to $582.5 million in 2025, then dropped by 5.74% to $549.0 million in 2026.
• Per Business Quant, the three latest ACT Cash & Equivalents figures stand at $549.0 million (Q1 2026), $582.5 million (Q4 2025), and $543.6 million (Q3 2025).